Surgery Partners (SGRY) Tops Q4 EPS by 16c
Surgery Partners (NASDAQ: SGRY) reported Q4 EPS of $0.35, $0.16 better than the analyst estimate of $0.19. Revenue for the quarter came in at $263 million versus the consensus estimate of $246.7 million.
Same-facility revenue increased 13.5% to $272.0 million as compared to the fourth quarter in 2014.
GUIDANCE:
Surgery Partners sees FY2016 revenue of $1.10-1.14 billion, versus the consensus of $1.05 billion.
For earnings history and earnings-related data on Surgery Partners (SGRY) click here.
